Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $691.82 million. The enterprise value is $471.75 million.
| Market Cap | 691.82M |
| Enterprise Value | 471.75M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 59.38 million shares outstanding. The number of shares has increased by 13.46% in one year.
| Current Share Class | 59.38M |
| Shares Outstanding | 59.38M |
| Shares Change (YoY) | +13.46% |
| Shares Change (QoQ) | +1.84% |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 68.85% |
| Float | 53.90M |
Valuation Ratios
The trailing PE ratio is 12.13 and the forward PE ratio is 13.65.
| PE Ratio | 12.13 |
| Forward PE | 13.65 |
| PS Ratio | 5.08 |
| Forward PS | 4.26 |
| PB Ratio | 3.18 |
| P/TBV Ratio | 3.34 |
| P/FCF Ratio | 21.21 |
| P/OCF Ratio | 20.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.63, with an EV/FCF ratio of 14.46.
| EV / Earnings | 8.24 |
| EV / Sales | 3.47 |
| EV / EBITDA | 11.63 |
| EV / EBIT | 12.08 |
| EV / FCF | 14.46 |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.17 |
| Quick Ratio | 5.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.05 |
| Interest Coverage | 6.84 |
Financial Efficiency
Return on equity (ROE) is 34.80% and return on invested capital (ROIC) is 1,679.05%.
| Return on Equity (ROE) | 34.80% |
| Return on Assets (ROA) | 8.74% |
| Return on Invested Capital (ROIC) | 1,679.05% |
| Return on Capital Employed (ROCE) | 15.38% |
| Weighted Average Cost of Capital (WACC) | 10.15% |
| Revenue Per Employee | $2.23M |
| Profits Per Employee | $938,475 |
| Employee Count | 61 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, ZVRA has paid $11.03 million in taxes.
| Income Tax | 11.03M |
| Effective Tax Rate | 15.91% |
Stock Price Statistics
The stock price has increased by +50.32% in the last 52 weeks. The beta is 0.95, so ZVRA's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +50.32% |
| 50-Day Moving Average | 11.82 |
| 200-Day Moving Average | 10.38 |
| Relative Strength Index (RSI) | 46.32 |
| Average Volume (20 Days) | 851,127 |
Short Selling Information
The latest short interest is 5.77 million, so 9.72% of the outstanding shares have been sold short.
| Short Interest | 5.77M |
| Short Previous Month | 6.47M |
| Short % of Shares Out | 9.72% |
| Short % of Float | 10.71% |
| Short Ratio (days to cover) | 6.05 |
Income Statement
In the last 12 months, ZVRA had revenue of $136.07 million and earned $57.25 million in profits. Earnings per share was $0.96.
| Revenue | 136.07M |
| Gross Profit | 129.89M |
| Operating Income | 39.07M |
| Pretax Income | 69.29M |
| Net Income | 57.25M |
| EBITDA | 40.55M |
| EBIT | 39.07M |
| Earnings Per Share (EPS) | $0.96 |
Balance Sheet
The company has $221.57 million in cash and $1.50 million in debt, with a net cash position of $220.07 million or $3.71 per share.
| Cash & Cash Equivalents | 221.57M |
| Total Debt | 1.50M |
| Net Cash | 220.07M |
| Net Cash Per Share | $3.71 |
| Equity (Book Value) | 217.65M |
| Book Value Per Share | 3.67 |
| Working Capital | 202.67M |
Cash Flow
In the last 12 months, operating cash flow was $33.40 million and capital expenditures -$775,000, giving a free cash flow of $32.62 million.
| Operating Cash Flow | 33.40M |
| Capital Expenditures | -775,000 |
| Depreciation & Amortization | 1.49M |
| Net Borrowing | -60.09M |
| Free Cash Flow | 32.62M |
| FCF Per Share | $0.55 |
Margins
Gross margin is 95.46%, with operating and profit margins of 28.71% and 42.82%.
| Gross Margin | 95.46% |
| Operating Margin | 28.71% |
| Pretax Margin | 50.92% |
| Profit Margin | 42.82% |
| EBITDA Margin | 29.80% |
| EBIT Margin | 28.71% |
| FCF Margin | 23.98% |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.46% |
| Shareholder Yield | -13.46% |
| Earnings Yield | 8.27% |
| FCF Yield | 4.72% |
Analyst Forecast
The average price target for ZVRA is $25.00, which is 114.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 114.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 27.61% |
| EPS Growth Forecast (3Y) | 7.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 1:16.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:16 |
Scores
ZVRA has an Altman Z-Score of 3.92 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.92 |
| Piotroski F-Score | 5 |